Where hypertension happens

Journal of Clinical Investigation

Volumn 123, Issue 5, 2013, Pages 1934-1936

  Reudelhuber, Timothy L ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR;

BLOOD PRESSURE; BLOOD VOLUME; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; HYPERTENSION; KIDNEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESISTANT HYPERTENSION; REVIEW; SODIUM BALANCE; SODIUM RETENTION;

EID: 84877111817     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI69296     Document Type: Review

References (12)

1. Chobanian AV, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572.
2. Dahl LK, Heine M. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ Res. 1975;36(6):692-696.
3. Bianchi G, Fox U, Di Francesco GF, Giovanetti AM, Pagetti D. Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med. 1974;47(5):435-448.
4. Grisk O, et al. Long-term arterial pressure in spontaneously hypertensive rats is set by the kidney. J Hypertens. 2002;20(1):131-138.
5. Crowley SD, et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A. 2006;103(47):17985-17990.
6. Juillerat L, et al. Determinants of angiotensin II generation during converting enzyme inhibition. Hypertension. 1990;16(5):564-572.
7. Gonzalez-Villalobos RA, et al. The absence of intrarenal ACE protects against hypertension. J Clin Invest. 2013;123(5):2011-2023.
8. Gribouval O, et al. Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis. Hum Mutat. 2012;33(2):316-326.
9. Matsusaka T, et al. Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol. 2012;23(7):1181-1189.
10. Marc Y, Llorens-Cortes C. The role of the brain renin-angiotensin system in hypertension: implications for new treatment. Prog Neurobiol. 2011;95(2):89-103.
11. Foss JD, Fink GD, Osborn JW. Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation. Hypertension. 2013;61(4):806-811.
12. Persu A, Renkin J, Thijs L, Staessen JA. Renal denervation: ultima ratio or standard in treatment-resistant hypertension. Hypertension. 2012;60(3):596-606.